Consultant gynaecological oncologist, Dr Esther Moss, said the test could not only detect cancer recurrence more quickly but also avoid the need for confirmatory invasive biopsies and was undergoing further validation before being used in everyday clinical practice.
Trending
- Inference of secreted protein signaling activities in intercellular communication
- Tracking FDA expert review of Replimune’s melanoma treatment
- Activating RARβ to overcome immunomodulatory drug resistance in t(4;14) human myeloma
- Merseyside lung cancer patient first in world to get new vaccine
- SMARCA2 and SMARCA4-deficiency is associated with a distinct molecular and microenvironmental subtype of esophageal adenocarcinoma
- Relapsed childhood cancers show genomic scars left by previous therapy
- Introduction to BCMA-Directed Therapies in Relapsed/Refractory Multiple Myeloma
- Advancing Multidisciplinary Care and Health Equity in Metastatic Breast Cancer
Thursday, July 30
